Sakar Healthcare Limited has informed the Exchange regarding Appointment of Ms Hiral Patel as Independent Director of the company w.e.f. July 25, 2025 subject to approval of members/shareholders of the Company.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare's board, at its July 25, 2025 meeting, approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) and set September 23, 2025 as the date for the 21st AGM via video conferencing. Three new Independent Directors — Ms. Megha Samdani, Ms. Reeya Kothari, and Ms. Hiral Patel — were appointed for five-year terms, subject to shareholder approval. The board also appointed M/s. Nishant Pandya & Associates as Secretarial Auditors for FY26–FY30 and M/s. Dalwadi & Associates as Cost Auditors for FY26. On the management front, three senior personnel were appointed: Mr. Sudhir Ghule as Chief Operating Officer, Mr. Raviraj Karia as SVP (Finance & Accounts), and Mr. Nimesh Suthar as SVP (International Business), all effective July 25, 2025.
This is a broad housekeeping announcement covering routine results, AGM logistics, and governance strengthening. The addition of three independent directors and experienced senior managers (notably a new COO) signals board and management expansion, which is generally seen as positive for governance and execution. No material change in financials is implied here — investors should focus on the Q1 results referenced in the filing for business performance.